Birdwatch Note
2024-11-10 01:55:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
他の医薬品が、プラセボ対照試験を求められている、というのは完全な事実誤認です。 臨床試験においてはヘルシンキ宣言において下記の6pの通り、明確に有効な治療法がある場合に、プラセボを使う事を禁止されており、最善の治療法を対照群として用いる事が大前提となっています。 https://www.pmda.go.jp/files/000155535.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1855323434617872806
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1855429062841520624
- noteId - 1855429062841520624
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1731203735443
- tweetId - 1855323434617872806
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 他の医薬品が、プラセボ対照試験を求められている、というのは完全な事実誤認です。 臨床試験においてはヘルシンキ宣言において下記の6pの通り、明確に有効な治療法がある場合に、プラセボを使う事を禁止されており、最善の治療法を対照群として用いる事が大前提となっています。 https://www.pmda.go.jp/files/000155535.pdf
Note Ratings
| rated at | rated by | |
| 2024-11-10 17:11:57 -0600 | Rating Details | |
| 2024-11-10 14:42:07 -0600 | Rating Details | |
| 2024-11-10 10:17:55 -0600 | Rating Details | |
| 2024-11-10 07:53:14 -0600 | Rating Details | |
| 2024-11-10 06:49:55 -0600 | Rating Details | |
| 2024-11-10 06:05:35 -0600 | Rating Details | |
| 2024-11-10 05:40:53 -0600 | Rating Details | |
| 2024-11-10 04:57:28 -0600 | Rating Details | |
| 2024-11-10 03:58:01 -0600 | Rating Details | |
| 2024-11-10 01:04:04 -0600 | Rating Details | |
| 2024-11-10 00:44:21 -0600 | Rating Details | |
| 2024-11-10 00:43:19 -0600 | Rating Details | |
| 2024-11-10 00:13:00 -0600 | Rating Details | |
| 2024-11-09 21:47:53 -0600 | Rating Details | |
| 2024-11-09 20:21:34 -0600 | Rating Details | |
| 2024-11-11 00:35:32 -0600 | Rating Details | |
| 2024-11-10 09:39:42 -0600 | Rating Details | |
| 2024-11-10 05:51:22 -0600 | Rating Details | |
| 2024-11-09 22:49:17 -0600 | Rating Details | |
| 2024-11-09 21:16:46 -0600 | Rating Details |